 | • レポートコード：20QY06-08126 • 出版社/出版日：QYResearch / 2020年6月1日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、138ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品・医療 |
| Single User | ￥600,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥900,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,200,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社の当調査資料では、肺炎球菌ワクチンのグローバル市場について種類別（PPSV23、PCV7/13、PCV10）、用途別（子供、大人）、地域別（北米、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。 ・肺炎球菌ワクチン市場の概要 ・世界の主要地域別肺炎球菌ワクチン市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界の肺炎球菌ワクチン市場規模2015-2026：種類別（PPSV23、PCV7/13、PCV10） ・世界の肺炎球菌ワクチン市場規模2015-2026：用途別（子供、大人） ・肺炎球菌ワクチンの北米市場規模2015-2020 ・肺炎球菌ワクチンのヨーロッパ市場規模2015-2020 ・肺炎球菌ワクチンの中国市場規模2015-2020 ・肺炎球菌ワクチンの日本市場規模2015-2020 ・肺炎球菌ワクチンの東南アジア市場規模2015-2020 ・肺炎球菌ワクチンのインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 （Pfizer、GSK、MSD、Sanofipasteur、CDIBP） ・肺炎球菌ワクチンの製造コスト分析 ・販売チャネル、流通業者、顧客 ・肺炎球菌ワクチンの市場動向・機会・課題 ・調査の結論 |
Pneumococcal Vaccine is a kind of vaccine used to prevent infection caused by pneumococcal bacteria.
North America is the largest consumption market of Pneumococcal Vaccine with sales market share nearly 40% in 2015.
The second place is Europe, following North America with sales market share over 18% in 2016. Asia-Pacific is another important market of Pneumococcal Vaccine, enjoy nearly 16% sales market share in 2013, but the consumption experienced a sharp decrease due to approval of government departments in last few years.
Market Analysis and Insights: Global Pneumococcal Vaccine Market
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Pneumococcal Vaccine market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Pneumococcal Vaccine industry.
Based on our recent survey, we have several different scenarios about the Pneumococcal Vaccine YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ 7038.2 million in 2019. The market size of Pneumococcal Vaccine will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
Global Pneumococcal Vaccine Scope and Market Size
The global Pneumococcal Vaccine market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Pneumococcal Vaccine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Pneumococcal Vaccine market is segmented into
PPSV 23
PCV 7/13
PCV 10
Segment by Application, the Pneumococcal Vaccine market is segmented into
Child
Adult
The Pneumococcal Vaccine market is analysed and market size information is provided by regions (countries). Segment by Application, the Pneumococcal Vaccine market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Pneumococcal Vaccine Market Share Analysis
Pneumococcal Vaccine market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Pneumococcal Vaccine business, the date to enter into the Pneumococcal Vaccine market, Pneumococcal Vaccine product introduction, recent developments, etc.
The major vendors covered:
Pfizer
GSK
MSD
Sanofipasteur
CDIBP
…
1 Pneumococcal Vaccine Market Overview
1.1 Pneumococcal Vaccine Product Scope
1.2 Pneumococcal Vaccine Segment by Type
1.2.1 Global Pneumococcal Vaccine Sales by Type (2020-2026)
1.2.2 PPSV 23
1.2.3 PCV 7/13
1.2.4 PCV 10
1.3 Pneumococcal Vaccine Segment by Application
1.3.1 Global Pneumococcal Vaccine Sales Comparison by Application (2020-2026)
1.3.2 Child
1.3.3 Adult
1.4 Pneumococcal Vaccine Market Estimates and Forecasts (2015-2026)
1.4.1 Global Pneumococcal Vaccine Sales Growth Rate (2015-2026)
1.4.2 Global Pneumococcal Vaccine Revenue and Growth Rate (2015-2026)
1.4.3 Global Pneumococcal Vaccine Price Trends (2015-2026)
1.5 Coronavirus Disease 2019 (Covid-19): Pneumococcal Vaccine Industry Impact
1.5.1 How the Covid-19 is Affecting the Pneumococcal Vaccine Industry
1.5.1.1 Pneumococcal Vaccine Business Impact Assessment – Covid-19
1.5.1.2 Supply Chain Challenges
1.5.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.5.2 Market Trends and Pneumococcal Vaccine Potential Opportunities in the COVID-19 Landscape
1.5.3 Measures / Proposal against Covid-19
1.5.3.1 Government Measures to Combat Covid-19 Impact
1.5.3.2 Proposal for Pneumococcal Vaccine Players to Combat Covid-19 Impact
2 Pneumococcal Vaccine Estimate and Forecast by Region
2.1 Global Pneumococcal Vaccine Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Pneumococcal Vaccine Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Pneumococcal Vaccine Sales Market Share by Region (2015-2020)
2.2.2 Global Pneumococcal Vaccine Revenue Market Share by Region (2015-2020)
2.3 Global Pneumococcal Vaccine Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Pneumococcal Vaccine Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Pneumococcal Vaccine Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Pneumococcal Vaccine Estimates and Projections (2015-2026)
2.4.2 Europe Pneumococcal Vaccine Estimates and Projections (2015-2026)
2.4.3 China Pneumococcal Vaccine Estimates and Projections (2015-2026)
2.4.4 Japan Pneumococcal Vaccine Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Pneumococcal Vaccine Estimates and Projections (2015-2026)
2.4.6 India Pneumococcal Vaccine Estimates and Projections (2015-2026)
3 Global Pneumococcal Vaccine Competition Landscape by Players
3.1 Global Top Pneumococcal Vaccine Players by Sales (2015-2020)
3.2 Global Top Pneumococcal Vaccine Players by Revenue (2015-2020)
3.3 Global Pneumococcal Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pneumococcal Vaccine as of 2019)
3.4 Global Pneumococcal Vaccine Average Price by Company (2015-2020)
3.5 Manufacturers Pneumococcal Vaccine Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Pneumococcal Vaccine Players (Opinion Leaders)
4 Global Pneumococcal Vaccine Market Size by Type
4.1 Global Pneumococcal Vaccine Historic Market Review by Type (2015-2020)
4.1.1 Global Pneumococcal Vaccine Sales Market Share by Type (2015-2020)
4.1.2 Global Pneumococcal Vaccine Revenue Market Share by Type (2015-2020)
4.1.3 Global Pneumococcal Vaccine Price by Type (2014-2020)
4.2 Global Pneumococcal Vaccine Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Pneumococcal Vaccine Sales Forecast by Type (2021-2026)
4.2.2 Global Pneumococcal Vaccine Revenue Forecast by Type (2021-2026)
4.2.3 Global Pneumococcal Vaccine Price Forecast by Type (2021-2026)
5 Global Pneumococcal Vaccine Market Size by Application
5.1 Global Pneumococcal Vaccine Historic Market Review by Application (2015-2020)
5.1.1 Global Pneumococcal Vaccine Sales Market Share by Application (2015-2020)
5.1.2 Global Pneumococcal Vaccine Revenue Market Share by Application (2015-2020)
5.1.3 Global Pneumococcal Vaccine Price by Application (2015-2020)
5.2 Global Pneumococcal Vaccine Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Pneumococcal Vaccine Sales Forecast by Application (2021-2026)
5.2.2 Global Pneumococcal Vaccine Revenue Forecast by Application (2021-2026)
5.2.3 Global Pneumococcal Vaccine Price Forecast by Application (2021-2026)
3 North America Pneumococcal Vaccine Market Facts & Figures
3.2 North America Pneumococcal Vaccine Sales Market Share by Company (2015-2020)
3.3 North America Pneumococcal Vaccine Sales Market Share by Type (2015-2020)
3.4 North America Pneumococcal Vaccine Sales Market Share by Application (2015-2020)
4 Europe Pneumococcal Vaccine Market Facts & Figures
4.2 Europe Pneumococcal Vaccine Sales Market Share by Company (2015-2020)
4.3 Europe Pneumococcal Vaccine Sales Market Share by Type (2015-2020)
4.4 Europe Pneumococcal Vaccine Sales Market Share by Application (2015-2020)
5 China Pneumococcal Vaccine Market Facts & Figures
5.2 China Pneumococcal Vaccine Sales Market Share by Company (2015-2020)
5.3 China Pneumococcal Vaccine Sales Market Share by Type (2015-2020)
5.4 China Pneumococcal Vaccine Sales Market Share by Application (2015-2020)
6 Japan Pneumococcal Vaccine Market Facts & Figures
6.2 Japan Pneumococcal Vaccine Sales Market Share by Company (2015-2020)
6.3 Japan Pneumococcal Vaccine Sales Market Share by Type (2015-2020)
6.4 Japan Pneumococcal Vaccine Sales Market Share by Application (2015-2020)
7 Southeast Asia Pneumococcal Vaccine Market Facts & Figures
7.2 Southeast Asia Pneumococcal Vaccine Sales Market Share by Company (2015-2020)
7.3 Southeast Asia Pneumococcal Vaccine Sales Market Share by Type (2015-2020)
7.4 Southeast Asia Pneumococcal Vaccine Sales Market Share by Application (2015-2020)
8 India Pneumococcal Vaccine Market Facts & Figures
8.2 India Pneumococcal Vaccine Sales Market Share by Company (2015-2020)
8.3 India Pneumococcal Vaccine Sales Market Share by Type (2015-2020)
8.4 India Pneumococcal Vaccine Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Pneumococcal Vaccine Business
12.1 Pfizer
12.1.1 Pfizer Pneumococcal Vaccine Corporation Information
12.1.2 Pfizer Pneumococcal Vaccine Business Overview and Total Revenue
12.1.3 Pfizer Pneumococcal Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Pfizer Pneumococcal Vaccine Products Offered
12.1.5 Pfizer Recent Development
12.2 GSK
12.2.1 GSK Pneumococcal Vaccine Corporation Information
12.2.2 GSK Pneumococcal Vaccine Business Overview and Total Revenue
12.2.3 GSK Pneumococcal Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.2.4 GSK Pneumococcal Vaccine Products Offered
12.2.5 GSK Recent Development
12.3 MSD
12.3.1 MSD Pneumococcal Vaccine Corporation Information
12.3.2 MSD Pneumococcal Vaccine Business Overview and Total Revenue
12.3.3 MSD Pneumococcal Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.3.4 MSD Pneumococcal Vaccine Products Offered
12.3.5 MSD Recent Development
12.4 Sanofipasteur
12.4.1 Sanofipasteur Pneumococcal Vaccine Corporation Information
12.4.2 Sanofipasteur Pneumococcal Vaccine Business Overview and Total Revenue
12.4.3 Sanofipasteur Pneumococcal Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Sanofipasteur Pneumococcal Vaccine Products Offered
12.4.5 Sanofipasteur Recent Development
12.5 CDIBP
12.5.1 CDIBP Pneumococcal Vaccine Corporation Information
12.5.2 CDIBP Pneumococcal Vaccine Business Overview and Total Revenue
12.5.3 CDIBP Pneumococcal Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.5.4 CDIBP Pneumococcal Vaccine Products Offered
12.5.5 CDIBP Recent Development
…
13 Pneumococcal Vaccine Manufacturing Cost Analysis
13.1 Pneumococcal Vaccine Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Pneumococcal Vaccine
13.4 Pneumococcal Vaccine Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Pneumococcal Vaccine Distributors List
14.3 Pneumococcal Vaccine Customers
15 Market Dynamics
15.1 Market Trends
15.2 Opportunities and Drivers
15.3 Challenges
15.4 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Pneumococcal Vaccine Sales (K Doses) Growth Rate by Type (2020-2026)
Table 2. Global Pneumococcal Vaccine Sales (K Doses) Comparison by Application (2020-2026)
Table 3. COVID-19 Impact Global Market: (Four Pneumococcal Vaccine Market Size Forecast Scenarios)
Table 4. Opportunities and Trends for Pneumococcal Vaccine Players in the COVID-19 Landscape
Table 5. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 6. Key Regions/Countries Measures against Covid-19 Impact
Table 7. Proposal for Pneumococcal Vaccine Players to Combat Covid-19 Impact
Table 8. Global Market Pneumococcal Vaccine Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 9. Global Pneumococcal Vaccine Sales (K Doses) by Region (2015-2020)
Table 10. Global Pneumococcal Vaccine Sales Market Share by Region (2015-2020)
Table 11. Global Pneumococcal Vaccine Revenue (US$ Million) Market Share by Region (2015-2020))
Table 12. Global Pneumococcal Vaccine Revenue Share by Region (2015-2020)
Table 13. Global Pneumococcal Vaccine Sales (K Doses) Forecast by Region (2021-2026)
Table 14. Global Pneumococcal Vaccine Sales Market Share Forecast by Region (2021-2026)
Table 15. Global Pneumococcal Vaccine Revenue (US$ Million) Forecast by Region (2021-2026)
Table 16. Global Pneumococcal Vaccine Revenue Share Forecast by Region (2021-2026)
Table 17. Global Pneumococcal Vaccine (K Doses) of Key Companies (2015-2020)
Table 18. Global Pneumococcal Vaccine Sales Share by Company (2015-2020)
Table 19. Global Pneumococcal Vaccine Revenue (US$ Million) by Company (2015-2020)
Table 20. Global Pneumococcal Vaccine Revenue Share by Company (2015-2020)
Table 21. Global Pneumococcal Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pneumococcal Vaccine as of 2019)
Table 22. Global Pneumococcal Vaccine Average Price (USD/Dose) of Key Company (2015-2020)
Table 23. Manufacturers Pneumococcal Vaccine Manufacturing Sites and Area Served
Table 24. Manufacturers Pneumococcal Vaccine Product Type
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Main Points Interviewed from Key Pneumococcal Vaccine Players
Table 27. Global Pneumococcal Vaccine Sales (K Doses) by Type (2015-2020)
Table 28. Global Pneumococcal Vaccine Sales Share by Type (2015-2020)
Table 29. Global Pneumococcal Vaccine Revenue (US$ Million) Market Share by Type (2015-2020)
Table 30. Global Pneumococcal Vaccine Price (K Doses) by Type (2015-2020)
Table 31. Global Pneumococcal Vaccine Sales Share by Type (2021-2026)
Table 32. Global Pneumococcal Vaccine Revenue (US$ Million) Market Share by Type (2021-2026)
Table 33. Global Pneumococcal Vaccine Revenue Share by Type (2021-2026)
Table 34. Global Pneumococcal Vaccine Price (K Doses) by Type (2021-2026)
Table 35. Global Pneumococcal Vaccine Sales (K Doses) by Application (2015-2020)
Table 36. Global Pneumococcal Vaccine Sales Share by Application (2015-2020)
Table 37. Global Pneumococcal Vaccine Revenue (US$ Million) Market Share by Application (2015-2020)
Table 38. Global Pneumococcal Vaccine Price (K Doses) by Application (2015-2020)
Table 39. Global Pneumococcal Vaccine Sales (K Doses) by Application (2021-2026)
Table 40. Global Pneumococcal Vaccine Sales Share by Application (2021-2026)
Table 41. Global Pneumococcal Vaccine Revenue (US$ Million) Market Share by Application (2021-2026)
Table 42. Global Pneumococcal Vaccine Revenue Share by Application (2021-2026)
Table 43. Global Pneumococcal Vaccine Price (K Doses) by Application (2021-2026)
Table 44. United States Pneumococcal Vaccine Sales (K Doses) by Company (2015-2020)
Table 45. United States Pneumococcal Vaccine Sales Market Share by Company (2015-2020)
Table 46. United States Pneumococcal Vaccine Sales (K Doses) by Type (2015-2020)
Table 47. United States Pneumococcal Vaccine Sales Market Share by Type (2015-2020)
Table 48. United States Pneumococcal Vaccine Sales (K Doses) by Application (2015-2020)
Table 49. United States Pneumococcal Vaccine Sales Market Share by Application (2015-2020)
Table 50. Europe Pneumococcal Vaccine Sales (K Doses) by Company (2015-2020)
Table 51. Europe Pneumococcal Vaccine Sales Market Share by Company (2015-2020)
Table 52. Europe Pneumococcal Vaccine Sales (K Doses) by Type (2015-2020)
Table 53. Europe Pneumococcal Vaccine Sales Market Share by Type (2015-2020)
Table 54. Europe Pneumococcal Vaccine Sales (K Doses) by Application (2015-2020)
Table 55. Europe Pneumococcal Vaccine Sales Market Share by Type (2015-2020)
Table 56. China Pneumococcal Vaccine Sales (K Doses) by Company (2015-2020)
Table 57. China Pneumococcal Vaccine Sales Market Share by Company (2015-2020)
Table 58. China Pneumococcal Vaccine Sales (K Doses) by Type (2015-2020)
Table 59. China Pneumococcal Vaccine Sales Market Share by Type (2015-2020)
Table 60. China Pneumococcal Vaccine Sales (K Doses) by Application (2015-2020)
Table 61. China Pneumococcal Vaccine Sales Market Share by Application (2015-2020)
Table 62. Japan Pneumococcal Vaccine Sales (K Doses) by Company (2015-2020)
Table 63. Japan Pneumococcal Vaccine Sales Market Share by Company (2015-2020)
Table 64. Japan Pneumococcal Vaccine Sales (K Doses) by Type (2015-2020)
Table 65. Japan Pneumococcal Vaccine Sales Market Share by Type (2015-2020)
Table 66. Japan Pneumococcal Vaccine Sales (K Doses) by Application (2015-2020)
Table 67. Japan Pneumococcal Vaccine Sales Market Share by Application (2015-2020)
Table 68. Southeast Asia Pneumococcal Vaccine Sales (K Doses) by Company (2015-2020)
Table 69. Southeast Asia Pneumococcal Vaccine Sales Market Share by Company (2015-2020)
Table 70. Southeast Asia Pneumococcal Vaccine Sales (K Doses) by Type (2015-2020)
Table 71. Southeast Asia Pneumococcal Vaccine Sales Market Share by Type (2015-2020)
Table 72. Southeast Asia Pneumococcal Vaccine Sales (K Doses) by Type (2015-2020)
Table 73. Southeast Asia Pneumococcal Vaccine Sales Market Share by Application (2015-2020)
Table 74. India Pneumococcal Vaccine Sales (K Doses) by Company (2015-2020)
Table 75. India Pneumococcal Vaccine Sales Market Share by Company (2015-2020)
Table 76. India Pneumococcal Vaccine Sales (K Doses) by Type (2015-2020)
Table 77. India Pneumococcal Vaccine Sales Market Share by Type (2015-2020)
Table 78. India Pneumococcal Vaccine Sales (K Doses) by Application (2015-2020)
Table 79. India Pneumococcal Vaccine Sales Market Share by Application (2015-2020)
Table 80. Pfizer Corporation Information
Table 81. Pfizer Description and Business Overview
Table 82. Pfizer Pneumococcal Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 83. Pfizer Pneumococcal Vaccine Product
Table 84. Pfizer Recent Development
Table 85. GSK Corporation Information
Table 86. GSK Description and Business Overview
Table 87. GSK Pneumococcal Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 88. GSK Pneumococcal Vaccine Product
Table 89. GSK Recent Development
Table 90. MSD Corporation Information
Table 91. MSD Description and Business Overview
Table 92. MSD Pneumococcal Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 93. MSD Pneumococcal Vaccine Product
Table 94. MSD Recent Development
Table 95. Sanofipasteur Corporation Information
Table 96. Sanofipasteur Description and Business Overview
Table 97. Sanofipasteur Pneumococcal Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 98. Sanofipasteur Pneumococcal Vaccine Product
Table 99. Sanofipasteur Recent Development
Table . CDIBP Corporation Information
Table . CDIBP Description and Business Overview
Table . CDIBP Pneumococcal Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table . CDIBP Pneumococcal Vaccine Product
Table . CDIBP Recent Development
Table 105. Production Base and Market Concentration Rate of Raw Material
Table 106. Key Suppliers of Raw Materials
Table 107. Pneumococcal Vaccine Distributors List
Table 108. Pneumococcal Vaccine Customers List
Table 109. Market Key Trends
Table 110. Key Opportunities and Drivers: Impact Analysis (2020-2026)
Table 111. Key Challenges
Table 112. Research Programs/Design for This Report
Table 113. Key Data Information from Secondary Sources
Table 114. Key Data Information from Primary Sources
List of Figures
Figure 1. Pneumococcal Vaccine Product Picture
Figure 2. Global Pneumococcal Vaccine Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Pneumococcal Vaccine Market Share by Application in 2020 & 2026
Figure 6. Child Examples
Figure 7. Adult Examples
Figure 8. Global Pneumococcal Vaccine Sales (K Doses) Growth Rate (2015-2026)
Figure 9. Global Pneumococcal Vaccine Revenue (US$ Million) Growth Rate (2015-2026)
Figure 10. Global Pneumococcal Vaccine Price Trends Growth Rate (2015-2026) (USD/Dose)
Figure 11. Global Pneumococcal Vaccine Revenue Market Share by Region: 2015 VS 2020
Figure 12. Global Pneumococcal Vaccine Revenue Market Share by Region: 2021 VS 2026
Figure 13. United States Pneumococcal Vaccine Revenue (Million USD) Growth Rate (2015-2026)
Figure 14. United States Pneumococcal Vaccine Sales (K Doses) Growth Rate (2015-2026)
Figure 15. Europe Pneumococcal Vaccine Revenue (Million USD) Growth Rate (2015-2026)
Figure 16. Europe Pneumococcal Vaccine Sales (Million USD) Growth Rate (2015-2026)
Figure 17. China Pneumococcal Vaccine Revenue (Million USD) Growth Rate (2015-2026)
Figure 18. China Pneumococcal Vaccine Sales (Million USD) and Growth Rate (2015-2026)
Figure 19. Japan Pneumococcal Vaccine Revenue (Million USD) Growth Rate (2015-2026)
Figure 20. Japan Pneumococcal Vaccine Sales (Million USD) Growth Rate (2015-2026)
Figure 21. Southeast Asia Pneumococcal Vaccine Revenue (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia Pneumococcal Vaccine Sales (Million USD) Growth Rate (2015-2026)
Figure 23. India Pneumococcal Vaccine Revenue (Million USD) Growth Rate (2015-2026)
Figure 24. India Pneumococcal Vaccine Sales (Million USD) Growth Rate (2015-2026)
Figure 25. Global 5 Largest Pneumococcal Vaccine Players Market Share by Revenue in Pneumococcal Vaccine 2015 & 2019
Figure 26. Pneumococcal Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 27. Global Pneumococcal Vaccine Revenue Share by Type (2015-2020)
Figure 28. Global Pneumococcal Vaccine Revenue Growth Rate by Type in 2015 & 2019
Figure 29. Global Pneumococcal Vaccine Revenue Share by Application (2015-2020)
Figure 30. Global Pneumococcal Vaccine Revenue Growth Rate by Application in 2015 & 2019
Figure 31. United States Pneumococcal Vaccine Sales Market Share by Type in 2019
Figure 32. United States Pneumococcal Vaccine Sales Market Share by Type in 2019
Figure 33. Europe Pneumococcal Vaccine Sales Market Share by Company in 2019
Figure 34. Europe Pneumococcal Vaccine Sales Market Share by Type in 2019
Figure 35. Europe Pneumococcal Vaccine Sales Market Share by Application in 2019
Figure 36. China Pneumococcal Vaccine Sales Market Share by Company in 2019
Figure 37. China Pneumococcal Vaccine Sales Market Share by Type in 2019
Figure 38. China Pneumococcal Vaccine Sales Market Share by Application in 2019
Figure 39. Japan Pneumococcal Vaccine Sales Market Share by Company in 2019
Figure 40. Japan Pneumococcal Vaccine Sales Market Share by Type in 2019
Figure 41. Japan Pneumococcal Vaccine Sales Market Share by Application in 2019
Figure 42. Southeast Asia Pneumococcal Vaccine Sales Market Share by Company in 2019
Figure 43. Southeast Asia Pneumococcal Vaccine Sales Market Share by Type in 2019
Figure 44. Southeast Asia Pneumococcal Vaccine Sales Market Share by Application in 2019
Figure 45. India Pneumococcal Vaccine Sales Market Share by Company in 2019
Figure 46. India Pneumococcal Vaccine Sales Market Share by Type in 2019
Figure 47. India Pneumococcal Vaccine Sales Market Share by Application in 2019
Figure 48. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 49. GSK Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. MSD Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. Sanofipasteur Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. CDIBP Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. Key Raw Materials Price Trend
Figure 54. Manufacturing Cost Structure of Pneumococcal Vaccine
Figure 55. Manufacturing Process Analysis of Pneumococcal Vaccine
Figure 56. Pneumococcal Vaccine Industrial Chain Analysis
Figure 57. Channels of Distribution
Figure 58. Distributors Profiles
Figure 59. Porter's Five Forces Analysis
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
多価肺炎球菌ワクチンの世界市場レポート2020 Pneumococcal vaccines are vaccines against the bacteria Streptococcus pneumoniae. Their use can prevent some cases of pneumonia, meningitis, and sepsis. Market Analysis and Insights: Global Pneumococcal Vaccine Polyvalent Market The global Pneumococcal Vaccine Polyvalent market was valued at US$ xx …- 肺炎球菌ワクチンの世界市場 2020年：メーカー別、地域別、種類・用途別 Summary Market Overview The global Pneumococcal Vaccine market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 1.1% in the forecast period of 2020 to 2025 and will expected to reach USD 7551.8 million by 2025, from USD 7242 million in 2019. The Pneumococ…
- 全ワクチンの世界市場レポート2020 A recently published report by QY Research titled Global All Vaccine Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides accurate data i…
- 共役ワクチンの世界市場レポート2020 A recently published report by QY Research titled Global Conjugate Vaccine Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides accurate …
- ライム病ワクチンの世界市場レポート2020 Market Analysis and Insights: Global Lyme Disease Vaccine Market The global Lyme Disease Vaccine market was valued at US$ xx million in 2019 and will reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2020-2026. Global Lyme Disease Vaccine Scope and Market Size The global Lyme …